AI Unlocks New Paths to Alzheimer’s Cure

Alzheimer’s disease remains one of the most heartbreaking and complex neurological disorders of our time. It affects more than six million Americans and costs the U.S. economy hundreds of billions of dollars each year in care and lost productivity. Despite decades of research and billions spent on drug development, progress has been slow—marked by high failure rates, unpredictable clinical trial outcomes, and a limited understanding of how the disease truly unfolds in the human brain. But now, a new frontier in biotech is emerging one powered not just by biologists and chemists, but by data scientists and machine learning engineers. Armed with artificial intelligence and massive, multimodal datasets, researchers are taking a radically different approach to cracking the Alzheimer’s